Probiotics and mastitis: Evidence-based marketing?

International Breastfeeding Journal

Volumn 11, Issue 1, 2016, Pages

  Amir, Lisa H ^a   Griffin, Laura ^b   Cullinane, Meabh ^a   Garland, Suzanne M ^c,d,e  

^a LA TROBE UNIVERSITY   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Mastitis; Microbiome; Probiotics; Treatment

Indexed keywords

EID: 84978910613     PISSN: None     EISSN: 17464358     Source Type: Journal    
DOI: 10.1186/s13006-016-0078-5     Document Type: Note

References (55)

1. Blaser MJ. The human microbiome, Missing Microbes: How the overuse of antibiotics is fueling our modern plagues. New York: Henry Holt and Company; 2014. p. 22-39.
2. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60(1):49-54.
3. Blaser M. Antibiotic overuse: Stop the killing of beneficial bacteria. Nature. 2011;476(7361):393-4.
4. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96(3):544-51.
5. Hickey L, Jacobs SE, Garland SM, ProPrems Study Group. Probiotics in neonatology. J Paediatr Child Health. 2012;48(9):777-83.
6. Garland SM, Tobin JM, Pirotta M, Tabrizi SN, Opie G, Donath S, Tang ML, Morley CJ, Hickey L, Ung L, et al. The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis. 2011;11:210.
7. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, Morley CJ, Garland SM, ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055-62.
8. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR, Probiotics in Preterm Infants Study Collaborative G. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet. 2015.
9. van Loveren H, Sanz Y, Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol. 2012;3:247-61.
10. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:CD005496.
11. Zuccotti G, Meneghin F, Aceti A, Barone G, Callegari ML, Di Mauro A, Fantini MP, Gori D, Indrio F, Maggio L et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70(11):1356-71.
12. Ward TL, Hosid S, Ioshikhes I, Altosaar I. Human milk metagenome: a functional capacity analysis. BMC Microbiol. 2013;13:116.
13. Olivares M, Diaz-Ropero MP, Martin R, Rodriguez JM, Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol. 2006;101(1):72-9.
14. Jimenez E, Fernandez L, Maldonado A, Martin R, Olivares M, Xaus J, Rodriguez JM. Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol. 2008;74(15):4650-5.
15. Arroyo R, Martin V, Maldonado A, Jimenez E, Fernandez L, Rodriguez JM. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis. 2010;50(12):1551-8.
16. Martin R, Olivares M, Marin ML, Fernandez L, Xaus J, Rodriguez JM. Probiotic potential of 3 Lactobacilli strains isolated from breast milk. J Hum Lact. 2005;21(1):8-17.
17. Diaz-Ropero MP, Martin R, Sierra S, Lara-Villoslada F, Rodriguez JM, Xaus J, Olivares M. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007;102(2):337-43.
18. Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, Serrant P, Segura-Roggero I, Schiffrin EJ, Donnet-Hughes A. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics. 2007;119(3):e724-32.
19. Donnet-Hughes A, Perez PF, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P, Segura-Roggero I, Schiffrin EJ. Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc Nutr Soc. 2010;69(3):407-15.
20. Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Bjorksten B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49(3):349-54.
21. Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr. 2004;38(3):293-7.
22. Klostermann K, Crispie F, Flynn J, Ross RP, Hill C, Meaney W. Intramammary infusion of a live culture of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials. J Dairy Res. 2008;75(3):365-73.
23. Greene WA, Gano AM, Smith KL, Hogan JS, Todhunter DA. Comparison of probiotic and antibiotic intramammary therapy of cattle with elevated somatic cell counts. J Dairy Sci. 1991;74(9):2976-81.
24. Beecher C, Daly M, Berry DP, Klostermann K, Flynn J, Meaney W, Hill C, McCarthy TV, Ross RP, Giblin L. Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression. J Dairy Res. 2009;76(3):340-8.
25. Crispie F, Alonso-Gomez M, O'Loughlin C, Klostermann K, Flynn J, Arkins S, Meaney W, Paul Ross R, Hill C. Intramammary infusion of a live culture for treatment of bovine mastitis: effect of live lactococci on the mammary immune response. J Dairy Res. 2008;75(3):374-84.
26. Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol. 2002;34(4):245-53.
27. Amir LH, The Academy of Breastfeeding Medicine Protocol Committee. ABM Clinical Protocol # 4: Mastitis, Revision, March 2014. Breastfeed Med. 2014;9(5):239-43.
28. World Health Organization. Mastitis: Causes and Management. Geneva: WHO/FCH/CAH/00.13; 2000.
29. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Melbourne: Therapeutic Guidelines Ltd.; 2010.
30. Amir LH, Forster D, McLachlan H, Lumley J. Incidence of breast abscess in lactating women: report from an Australian cohort. BJOG. 2004;111(12):1378-81.
31. Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti Infect Ther. 2014;12(7):753-62.
32. McDonald K, Amir LH, Davey M-A. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011;11 Suppl 5:S5.
33. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynec. 2006;107(5):1120-38.
34. Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis. [https://clinicaltrials.gov/ct2/show/NCT00716183]
35. Amir LH. Managing common breastfeeding problems in the community. BMJ. 2014;348:g2954.
36. McGuire E, Tawia S. Probiotics are the new black. Breastfeed Rev. 2014;22(3):33-41.
37. Fernandez L, Cardenas N, Arroyo R, Manzano S, Jimenez E, Martin V, Rodriguez JM. Prevention of infectious mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy. Clin Infect Dis. 2016;62(5):568-73.
38. Amir LH, Trupin S, Kvist LJ. Diagnosis and treatment of mastitis in breastfeeding women. J Hum Lact. 2014;30(1):10-3.
39. Study to assess the preventive effect of new probiotic strain on lactational mastitis. [http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4388]
40. Probiotics for the Prevention of Mastitis in Breastfeeding Women: A Randomised Controlled Trial. [https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12615000923561]
41. Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis. [http://clinicaltrials.gov/show/NCT02203877]
42. Therapeutic Goods Act 1989 (Cth) Chapter 5. 1989.
43. Therapeutic Goods Advertising Code (Cth). 2007.
44. Australian Consumer Law. s 18.
45. Sterling Winthrop Pty Ltd v Boots Co (Aust) Pty Ltd (1995) 32 IPR 361.
46. Australian Consumer Law. s 4(1).
47. Trotman Australia Pty Ltd v Hobsons Press (Aust) Pty Ltd (1991) 22 IPR 397. 403.
48. Metcalfe v NZI Securities Australia Ltd (1995) ATPR ¶41-418 at 40,671; BC9507736.; 1995.
49. Janssen Pharmaceutical Pty Ltd v Pfizer Pty Ltd (1985) 6 IPR 227 at 234. 1985.
50. Peterson v Merck Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1.
51. Colgate-Palmolive Pty Ltd v Rexona Pty Ltd (1981) 58 FLR 391. 401-402.
52. Hornsby Building Information Centre Pty Ltd v Sydney Building Information Centre Ltd (1978) 140 CLR 216.
53. Yorke and Lucas (1985) 158 CLR 661.
54. Blaser MJ. Solutions, Missing Microbes: How the overuse of antibiotics is fueling our modern plagues. New York: Henry Holt and Company; 2014. p. 199-217.
55. Arribas B, Rodriguez-Cabezas ME, Comalada M, Bailon E, Camuesco D, Olivares M, Xaus J, Zarzuelo A, Galvez J. Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr. 2009;101(1):51-8.